Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0043-1768168
Clinicopathological, Immunological, and Laboratory Parameters of Childhood Lupus Nephritis: A Study from Northeast India
Funding None.![](https://www.thieme-connect.de/media/10.1055-s-00044881/202303/lookinside/thumbnails/10-1055-s-0043-1768168_2291408-1.jpg)
Abstract
Background Lupus nephrtis in children is associated with high morbidity and mortality. The incidence of childhood systemic lupus erythematosus (SLE) ranges from 3.3 to 8.8/100000 children with a higher Asian preponderance. The predominance of SLE in female pediatric patients increases gradually with age to the values observed in adults.
Objectives To assess the clinical, immunological, and histopathological spectrum of childhood lupus nephritis in northeast India and explore the relationship between clinical, biochemical, serological, and histopathological findings.
Materials and Methods A retrospective descriptive study was performed over 8 years. Histopathology slides were reviewed by two pathologists, whereas other details were collected from patients' records.
Statistical Analysis Statistical analysis was based on the chi-square test and a p-value < 0.05 was considered statistically significant.
Results Fifty-three cases of lupus nephritis were included in the study. The patients' age ranged from 5 to 18 years with a mean age of 14.5 years and a female: male ratio of 6.5:1. Edema and hypertension were the commonest clinical presentations, whereas proteinuria was the commonest presenting laboratory parameter. Amongst all the immunological markers, dsDNA was the commonest. Histopathologically, predominantly study population belonged to class IV lupus nephritis. The patients with class IV showed a statistically significant correlation with proteinuria and hematuria at the time of diagnosis. Immunological markers, namely, ANA and anti-ds-DNA positivity were significantly associated with advanced renal histopathology.
Conclusion cSLE in northeast India presents mostly as Class IV LN presenting mostly with deranged laboratory parameters and preponderance of various immunological markers and clinical presentations.
Consent
The study was performed respecting the Declaration of Helsinki. Proper consent was taken for the study from the caretaker and identity of the patient was kept confidential.
Publication History
Article published online:
18 April 2023
© 2023. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am 2012; 59 (02) 345-364
- 2 Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23 (11) 1981-1987
- 3 Wenderfer SE, Ruth NM, Brunner HI. Advances in the care of children with lupus nephritis. Pediatr Res 2017; 81 (03) 406-414
- 4 Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010; 6 (09) 538-546
- 5 Oni L, Wright RD, Marks S, Beresford MW, Tullus K. Kidney outcomes for children with lupus nephritis. Pediatr Nephrol 2021; 36 (06) 1377-1385
- 6 Pereira MV, Revelo MP, Bambirra EA. Lupic nephropathy in childhood: morphologic analysis of 18 cases [article in Portuguese]. J Pediatr (Rio J) 1996; 72 (01) 32-34
- 7 Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different from adult SLE?. Int J Rheum Dis 2015; 18 (02) 182-191
- 8 Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol 2017; 12 (05) 825-835
- 9 Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009; 36 (11) 2539-2546
- 10 Sinha R, Raut S. Pediatric lupus nephritis: management update. World J Nephrol 2014; 3 (02) 16-23
- 11 Ruggiero B, Vivarelli M, Gianviti A. et al. Lupus nephritis in children and adolescents: results of the Italian collaborative Study. Nephrol Dial Transplant 2013; 28 (06) 1487-1496
- 12 Al Salloum AA. Lupus nephritis in childhood. Saudi J Kidney Dis Transpl 2003; 14 (01) 43-56
- 13 Samanta M, Nandi M, Mondal R. et al. Childhood lupus nephritis: 12 years of experience from a developing country's perspective. Eur J Rheumatol 2017; 4 (03) 178-183
- 14 Jebali H, Hajji M, Rais L, Hamida FB, Beji S, Zouaghi MK. Clinicopathological findings and outcome of lupus nephritis in Tunisian children: a review of 43 patients. Pan Afr Med J 2017; 27: 153
- 15 Singh S, Abujam B, Gupta A. et al. Childhood lupus nephritis in a developing country-24 years' single-center experience from North India. Lupus 2015; 24 (06) 641-647
- 16 Cameron JS. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994; 8 (02) 230-249
- 17 Nandi M, Mondal R. Renal involvement in childhood lupus: a study from Kolkata, India. Saudi J Kidney Dis Transpl 2012; 23 (04) 871-875
- 18 Agarwal I, Kumar TS, Ranjini K, Kirubakaran C, Danda D. Clinical features and outcome of systemic lupus erythematosus. Indian Pediatr 2009; 46 (08) 711-715
- 19 Emre S, Bilge I, Sirin A. et al. Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron J 2001; 87 (02) 118-126
- 20 Mittal A, Bamnawat H, Nalwa A. et al. Pediatric onset lupus nephritis in western India-is it different from the rest of the country?. Lupus 2021; 30 (12) 2008-2016
- 21 Wu JY, Yeh KW, Huang JL. Early predictors of outcomes in pediatric lupus nephritis: focus on proliferative lesions. Semin Arthritis Rheum 2014; 43 (04) 513-520